ProCE Banner Activity

Improving Outcomes for Patients With CML With TKIs: FAQ Podcast

Podcast Episodes
Listen to leukemia experts Prof. Dr. med Tim Henrik Brümmendorf; Jorge Cortes, MD; and Carlo Gambacorti-Passerini, MD, answer audience questions from live CCO Webinars on optimizing TKI treatments for patients with chronic-phase chronic myeloid leukemia (CML).

Released: August 13, 2020

Expiration: August 12, 2021

Share

Faculty

Carlo Gambacorti-Passerini

Carlo Gambacorti-Passerini, MD

Professor, Hematology
University Milano Bicocca
Director, Hematology
San Gerardo Hospital
Monza, Italy

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.

Faculty Disclosure

Primary Author

Carlo Gambacorti-Passerini, MD

Professor, Hematology
University Milano Bicocca
Director, Hematology
San Gerardo Hospital
Monza, Italy

Carlo Gambacorti-Passerini, MD, has no relevant conflicts of interest to report.

Staff Disclosure

Staff

Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Katie Eustace, MBA

Senior Director, Global Medical Education, Europe

Katie Eustace has no relevant conflicts of interest to report.

Terrence Fagan,

Associate Scientific Director

Terrence Fagan has no relevant conflicts of interest to report.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin L. Obholz, PhD, has no relevant conflicts of interest to report.

Timothy A. Quill, PhD

Senior Managing Editor

Timothy A. Quill, PhD, has no relevant conflicts of interest to report.